» Articles » PMID: 35432442

Case Report: Identification of a Variant in a Patient With Mitochondrial Membrane Protein-Associated Neurodegeneration

Overview
Journal Front Genet
Date 2022 Apr 18
PMID 35432442
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondrial membrane protein-associated neurodegeneration (MPAN) mostly arises as an autosomal recessive disease and is caused by variants in the chromosome 19 open reading frame 12 () gene. However, a few monoallelic truncating variants have been reported and segregated as autosomal dominant traits in some cases. We performed whole-exome sequencing and analyzed genes related to neurodegeneration associated with brain iron accumulation for pathogenic variants. The identified variants were confirmed by Sanger sequencing and tested using tools. The patient had an onset of depression at the age of 22 years, which rapidly progressed to severe dystonia, dementia, and bladder and bowel incontinence. Neuroimaging showed hypointensity in the substantia nigra and the globus pallidum, with additional frontotemporal atrophy. Genetic analysis revealed a single complex variant [c.336_338delinsCACA (p.Trp112CysfsTer40)] in the gene. This study enriches the genetic spectrum and clinical features of variants and provides additional evidence of the variable inheritance pattern of MPAN.

Citing Articles

Mitochondrial-Membrane-Protein-Associated Neurodegeneration in Longitudinal Magnetic Resonance Imaging Over 11 Years of Follow-Up.

Lee J, Kim J, Lyoo C, Kim Y J Clin Neurol. 2024; 20(2):220-222.

PMID: 38433486 PMC: 10921055. DOI: 10.3988/jcn.2023.0336.


Identification of Autophagy as a Functional Target Suitable for the Pharmacological Treatment of Mitochondrial Membrane Protein-Associated Neurodegeneration (MPAN) In Vitro.

Zanuttigh E, Derderian K, Gura M, Geerlof A, Di Meo I, Cavestro C Pharmaceutics. 2023; 15(1).

PMID: 36678896 PMC: 9862353. DOI: 10.3390/pharmaceutics15010267.

References
1.
Gregory A, Lotia M, Jeong S, Fox R, Zhen D, Sanford L . Autosomal dominant mitochondrial membrane protein-associated neurodegeneration (MPAN). Mol Genet Genomic Med. 2019; 7(7):e00736. PMC: 6625130. DOI: 10.1002/mgg3.736. View

2.
Schulte E, Claussen M, Jochim A, Haack T, Hartig M, Hempel M . Mitochondrial membrane protein associated neurodegenration: a novel variant of neurodegeneration with brain iron accumulation. Mov Disord. 2013; 28(2):224-7. DOI: 10.1002/mds.25256. View

3.
Nagarjunakonda S, Daggumati R, Uppala V, Gajula R, Amalakanti S . A Novel Mutation in Neurodegeneration with Brain Iron Accumulation - A Case Report. Neurol India. 2019; 67(5):1341-1343. DOI: 10.4103/0028-3886.271257. View

4.
Dusek P, Skoloudik D, Roth J, Dusek P . Mitochondrial membrane protein-associated neurodegeneration: a case report and literature review. Neurocase. 2018; 24(3):161-165. DOI: 10.1080/13554794.2018.1506038. View

5.
Wang Z, Liu J, Xu X, Mao X, Zhang W, Zhou H . Neurodegeneration with brain iron accumulation: Insights into the mitochondria dysregulation. Biomed Pharmacother. 2019; 118:109068. DOI: 10.1016/j.biopha.2019.109068. View